In CGGA cohort, the Kaplan-Meier analysis verified that gliomas with higher expression levels of PVT1 experienced significantly shorter overall survival (OS) in both whole gliomas (p < 0.0001) and GBM (p = 0.0064) (Fig. 3A, B). This evidence concerns the gene PVT1 and glioblastoma.